# Fecal Microbial Transplantation in Relapsing Multiple Sclerosis Patients

> **NCT03183869** · PHASE2 · TERMINATED · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 14 (actual)

## Conditions studied

- Autoimmune Diseases
- Relapsing Multiple Sclerosis

## Interventions

- **DRUG:** Fecal microbiota

## Key facts

- **NCT ID:** NCT03183869
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-08-24
- **Primary completion:** 2018-11-19
- **Final completion:** 2019-01-25
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** Primary Investigator passed away.
- **Last updated:** 2019-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03183869

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03183869, "Fecal Microbial Transplantation in Relapsing Multiple Sclerosis Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03183869. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*